Acquisition History / Artivion, Inc. / Endospan Ltd.
Artivion, Inc. Acquires Endospan Ltd.
Announced May 18, 2026 — $175M
What happened
Endospan is an Israeli company that designs, develops and sells products for the treatment of aortic instability, including the NEXUS stent graft. Artivion completed the acquisition in May 2026 for a base purchase price of $175.0M paid entirely in cash, netting about $131.3M after offsetting prior loans.
- Acquirer
- Artivion, Inc.
- Target
- Endospan Ltd.
- Announced
- May 18, 2026
- Price
- $175M
- Industry
- Aortic stent graft devices
- Buyer type
- Strategic acquirer
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Artivion, Inc. acquire Endospan Ltd.?
Artivion, Inc. acquired Endospan Ltd. on May 18, 2026. This was Artivion, Inc.'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Artivion, Inc. pay for Endospan Ltd.?
Artivion, Inc. paid $175M for Endospan Ltd..
What does Endospan Ltd. do?
Endospan is an Israeli company that designs, develops and sells products for the treatment of aortic instability, including the NEXUS stent graft. Artivion completed the acquisition in May 2026 for a base purchase price of $175.0M paid entirely in cash, netting about $131.3M after offsetting prior loans.
What other Aortic stent graft devices companies has Artivion, Inc. acquired?
Endospan Ltd. is Artivion, Inc.'s only publicly tracked acquisition in Aortic stent graft devices so far.